awmsg logo



trabectedin (Yondelis®)


Reference No. 319

Excluded date:
04/12/2009


Appraisal information

trabectedin (Yondelis®) powder for concentrate for solution for infusion


Company: Pharma Mar SA
BNF category: Malignant disease and immunosupression
   
   
Submission Type: Not applicable
Status: Excluded

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ministerial
Ratification

Indication

In combination with pegylated liposomal doxorubicin (PLD) for the treatment of patients with relapsed platinum-sensitive ovarian cancer

AWMSG advice

Product meets AWMSG exclusion criteria due to NICE appraisal